SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 146 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q3 2017. The put-call ratio across all filers is 3.79 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $387,000 | -19.7% | 276,270 | -0.3% | 0.08% | -13.3% |
Q2 2018 | $482,000 | -7.1% | 277,110 | -2.3% | 0.09% | -10.9% |
Q1 2018 | $519,000 | -26.9% | 283,560 | -11.0% | 0.10% | -24.6% |
Q4 2017 | $710,000 | -19.3% | 318,460 | +4.9% | 0.13% | -23.4% |
Q3 2017 | $880,000 | -34.9% | 303,460 | +0.1% | 0.18% | -32.4% |
Q2 2017 | $1,352,000 | -1.7% | 303,060 | +2.7% | 0.26% | -6.8% |
Q1 2017 | $1,375,000 | +1.3% | 295,060 | +32.5% | 0.28% | -2.8% |
Q4 2016 | $1,357,000 | – | 222,760 | – | 0.29% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Asymmetry Capital Management, L.P. | 477,621 | $1,065,000 | 1.44% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 1,505,804 | $3,358,000 | 1.18% |
Nantahala Capital Management | 7,000,000 | $15,610,000 | 0.69% |
Hikari Power Ltd | 1,900,000 | $4,237,000 | 0.50% |
Trellus Management Company, LLC | 112,500 | $251,000 | 0.34% |
Cheyne Capital Management (UK) LLP | 206,500 | $462,000 | 0.20% |
KNOTT DAVID M | 201,400 | $449,000 | 0.18% |
Paulson & Co. | 4,000,000 | $8,920,000 | 0.17% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,041,695 | $2,323,000 | 0.15% |
Clear Harbor Asset Management, LLC | 318,460 | $710,000 | 0.13% |